![](https://investorshub.advfn.com/uicon/430424.png?cb=1554906782)
Thursday, January 09, 2014 11:19:57 PM
1. If the data on tumor reduction in the Direct trial is complete tumor reduction plus strong indications of systemic immune responses, and these results keep trickling out week after week on cancer type after cancer type, at some point the PPS (as well as the market cap) will explode.
2. If the 1st or 2nd interim data in the DCVAX- L trial are so strong that the trial is unblinded, the price will explode.
Market Cap is important for PPS, and I regret not being more clear on my first post regarding what PPS would do without further dilution.
Regardless, the upshot of mine and the others' last posts on calculating Market Cap to PPS are in agreement.
That said….
In my opinion, we will sail beyond a 7 billion market cap in very little time with positive news on numbers 1 or 2 above (and no bad news).
So if we go over 7 billion Market Cap, we will also be comfortably beyond $100.00 per share, as long as there are no new offerings between now and then. This PPS includes what the others wanted me to include the first time around -- existing warrants and options that will be exercised long before we reach $100.00 per share. Their figures would agree with this extrapolation.
So what does a 7 Billion Market share mean? If you know these companies, and what they produce or have in their pipeline, you can get a feel for what this number means. There are better examples, but this list is just a starting point.
1. CLDX = 1.88 Billion
2. CBST = 5.18 Billion
3. JAZZ = 7.86 Billion
4. PCYC = 9.62 Billion
5. Gilead =113 Billion
6. Roche = 242 Billion
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM